Yunnan Baiyao (000538)(000538)
Yunnan Baiyao Group Co., Ltd. is a company mainly engaged in chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines and biological products. The company's products are mainly Yunnan Baiyao series, Sanqi series and Yunnan national characteristic drugs series, with more than 200 products in *** 17 dosage form. Products sell well in the domestic market and Southeast Asia, and gradually enter the markets of developed countries such as Japan, Europe and America. The company is one of the well-known Chinese patent medicine manufacturers in China, one of the large industrial and commercial pharmaceutical enterprises in Yunnan, and one of the top 50 Chinese patent medicines in China. 1997 was recognized as one of the first 40 large enterprises and groups in Yunnan province. Yunnan Baiyao ranks first among the top ten traditional brands of Chinese medicine enterprises in the list of top ten enterprises in various fields of Chinese medicine industry released for the first time by the brand selection activity of 20 10 Chinese medicine industry brand summit. 20 17 September, Yunnan Baiyao was selected as "20 16" issued by China Pharmaceutical (600056) Industrial Information Center. ...
Chengzhi shares (000990)(000990)
The main business of Chengzhi Co., Ltd. includes the comprehensive management of industrial gases and basic chemical raw materials, the production and sales of semiconductor display materials, the production and sales of life science and technology products, and the cultivation, research and processing of industrial hemp and the sales of its products. The main products and services provided by the company include monochromatic liquid crystal materials such as CO, hydrogen and syngas, ethylene, propylene, butanol, octanol and isobutyraldehyde, TN and STN, TFT-LCD liquid crystal materials and organic light-emitting diode materials, D- ribose, L- glutamine, industrial hemp, and medical services such as diagnosis and treatment. As the only enterprise with complete intellectual property rights of D- ribose in the world, Chengzhi Bioengineering, a subsidiary, passed the audit of a strength certifiable company and obtained the AA certificate of BRCGS, which is the second time since 2020. Chengzhi Yonghua, a subsidiary of the company, is a high-tech enterprise, a state-level enterprise technology center and a subsidiary of China Optics and Optoelectronics. ...
Angel Yeast (600298)(600298)
Angel Yeast Co., Ltd. is engaged in the research, development, production and management of yeast, yeast derivatives and related biological products. The company's main products include: yeast and deep-processed products, health food, special nutritious food, baking raw materials, food additives, dairy products, condiments and so on. The company has formed a multi-service brand framework system, implemented brand segmentation in different professional fields, and built the strength of angel brand cluster. Angel brand has become an international brand with high popularity and wide influence. It is one of the top ten international registered enterprises in Madrid, China, and owns two well-known trademarks of China, Angel and Fubon. "Angel" was selected as the most valuable brand in China 100, and "Angel Newt" was selected as the "Top Ten Credibility Brands of Health Products in China" for five consecutive years. The company was awarded "China Top 100 Light Industry Enterprises", "China Top 10 Fermentation Enterprises", "China Main Board Listed Companies 100", "China Top 500 Listed Companies" and "Best". ...
Asia Pacific Pharmaceuticals (002370)(002370)
Zhejiang Yatai Pharmaceutical Co., Ltd. is mainly engaged in pharmaceutical manufacturing business, including research and development, production and sales of chemical preparations and chemical raw materials. The company's main products include anti-amoxicillin potassium clavulanate dispersible tablets, azithromycin dispersible tablets, azithromycin for injection, roxithromycin capsules and ceftizoxime sodium for injection. Roxithromycin capsules, cefalexin capsules, azithromycin dispersible tablets and azithromycin for injection are the leading products of our company. In 2007, the output of roxithromycin capsules ranked first in China, Cefalexin capsules ranked fourth in China and Azithromycin dispersible tablets ranked second in China.
Tasly (600535)(600535)
The main business of Tasly Pharmaceutical Group Co., Ltd. is drug research and development, production and sales. The company's products mainly include compound Danshen dripping pills, Yangxue Qingnao granules, Yiqi Fumai (freeze-dried) for injection, Tiqing, Shuijialing and other drugs.
Olkin (00270 1)
Olkin (00270 1) Technology Co., Ltd. is mainly committed to providing comprehensive packaging solutions for all kinds of fast-moving consumer goods customers. The main products of the company are metal packaging products and services.
Shuanglu Pharmacy (002038)(002038)
Beijing Shuanglu Pharmaceutical Co., Ltd. is mainly engaged in the research and development, production and management of genetic engineering and related drugs, and pays close attention to the changes of disease spectrum. The main products are recombinant human granulocyte stimulating factor, recombinant human interleukin-2, recombinant human interleukin-1 1, recombinant human basic fibroblast growth factor, temozolomide, arsenic trioxide, lenalidomide, complex coenzyme, thymopentin, enoxaparin sodium, loratadine dispersible tablets, telmisartan, docetaxel and adefovir dipivoxil. The company was selected as one of the key high-tech enterprises in the National Torch Plan, the first batch of "Top 100 Innovative Enterprises" in Haidian Park of Zhongguancun (00093 1) Science Park, the "Beijing Biomedical Industry Leaping Development Project" (G20 Project) and the first batch of "100,000 Projects" in Zhongguancun National Independent Innovation Demonstration Zone. 20 10-20 1 1 was rated as the most competitive for two consecutive years. ...
Kang (600572)(600572)
The main business of Zhejiang Kangenbei Pharmaceutical Co., Ltd. is the research and development, manufacture, wholesale and distribution of drugs and health care products. The company's main products are Qianliekang brand Pulean tablets and capsules, Tianbaoning brand Ginkgo biloba preparation, Kangenbei brand Changyanning, Jin Aokang brand omeprazole products, Di Chin brand compound Houttuynia mixture, Zhenshiming brand eye drops and eye care products, gold tetrandrine and Jin Kang Suli brand acetylcysteine. The company has been awarded the national innovative enterprise, the national modern Chinese medicine industrial base, the national recognized enterprise technology center and the national postdoctoral research center, and has established the Zhejiang Key Laboratory of Chinese Medicine Pharmaceutical Technology, the Zhejiang Key Enterprise Research Institute and the Zhejiang Modern Botanical Medicine High-tech R&D Center.
Angel Pharmacy (002118) (002118)
The main business of Jilin Angel Pharmaceutical Co., Ltd. is Chinese patent medicine industry, ginseng industry and industrial hemp industry. The company's main products are pills, tablets, hard capsules, oral liquid, granules, oral liquid, mixture, soft capsules, buccal tablets, ginseng products and industrial hemp products. The company's "Angel" trademarks are well-known trademarks in China and Jilin Province. The company was rated as "China Pharmaceutical Industry Quality Unit" and "Best Reputation Unit in Jilin Province"; No Counterfeiting Unit in China Pharmaceutical Industry; "AAA China Credit Enterprise".
Harbin Pharmaceutical Co., Ltd. (600664)(600664)
Harbin Pharmaceutical Group Co., Ltd. focuses on the medical and health industry, mainly engaged in pharmaceutical R&D and manufacturing, wholesale and retail business, and is a large domestic high-tech pharmaceutical enterprise integrating pharmaceutical R&D, manufacturing and sales. The company's main products are antivirus, anti-infection, cold medicine, cardiovascular and cerebrovascular diseases, digestive system, anti-tumor and nutritional supplements. At present, the company owns five well-known trademarks of Harbin Pharmaceutical Co., Ltd., Sanjing, Tang Shiyi, Gaizhonggai and Hutong, and the right to use Tang Shiyi 1 China Time-honored Brand. Accumulated awards include "China 100 Most Valuable Consumer Brand", "Self-owned Brand Enterprise with the Most Growth Force in the Industry", "Top Ten Brands in the International Market of China Industry", "Brand China Golden Spectrum Award-Top Ten Brands of the Year in China Pharmaceutical Industry", "Public Welfare Brand Award for Influencing China", "Leading Brand in China Industry" and "Top Ten Innovative Brand Award in China Industry". ...